Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Short-term Investments (2016 - 2025)

Cellectis has reported Short-term Investments over the past 10 years, most recently at $200000.0 for Q4 2025.

  • Quarterly results put Short-term Investments at $200000.0 for Q4 2025, down 99.83% from a year ago — trailing twelve months through Dec 2025 was $200000.0 (down 99.83% YoY), and the annual figure for FY2025 was $200000.0, down 99.83%.
  • Short-term Investments for Q4 2025 was $200000.0 at Cellectis, down from $117.1 million in the prior quarter.
  • Over the last five years, Short-term Investments for CLLS hit a ceiling of $117.1 million in Q4 2024 and a floor of $200000.0 in Q4 2025.
  • Median Short-term Investments over the past 5 years was $4.5 million (2022), compared with a mean of $30.3 million.
  • Biggest five-year swings in Short-term Investments: surged 1484.57% in 2022 and later crashed 99.83% in 2025.
  • Cellectis' Short-term Investments stood at $499000.0 in 2021, then surged by 1484.57% to $7.9 million in 2022, then skyrocketed by 595.59% to $55.0 million in 2023, then skyrocketed by 112.83% to $117.1 million in 2024, then crashed by 99.83% to $200000.0 in 2025.
  • The last three reported values for Short-term Investments were $200000.0 (Q4 2025), $117.1 million (Q4 2024), and $55.0 million (Q4 2023) per Business Quant data.